For bipolar medication that helps with weight loss, look towards anticonvulsants like topiramate (strong weight loss effect) or lamotrigine (neutral/loss), or GLP-1 agonists like liraglutide (Ozempic/Wegovy) for stable cases, while metformin helps prevent weight gain from antipsychotics; some combinations like olanzapine-samidorphan (Lybalvi) also reduce weight gain. Always consult your doctor, as the best choice depends on your specific needs, as some weight loss drugs can trigger mania.
Several studies have demonstrated the efficacy of topiramate in the treatment of bipolar disorder, including refractory populations, and in the treatment of posttraumatic stress disorder. Topiramate led to substantial weight loss in patients with bipolar disorders in these studies.
Effectiveness: Often used for bipolar depression, lamotrigine is noted for having a lower risk of weight gain. Considerations: It's generally well-tolerated but requires gradual dosing to avoid side effects such as rash.
Aripiprazole. This antipsychotic has been found to help some people lose weight when combined with another antipsychotic. Studies have shown the addition of aripiprazole helped people lose more than 4 pounds (about 2.1 kg) on average.
Bupropion and topiramate have the best evidence for long-term weight loss, while fluoxetine, stimulants, possibly lamotrigine, and atomoxetine may also help.
In short: A new study from researchers at the University of Queensland has found weight loss medications like Ozempic don't interfere with antipsychotic medications. Weight gain is one of the most common side effects for people on medication for schizophrenia and can lead to adverse health outcomes.
Healthy eating and a suitable amount of physical activity are givens. Research suggests that the quality and quantity of your sleep, surprisingly, influences appetite and weight gain. Creating and sticking to routines has powerful benefits for maintaining wellness when you live with bipolar.
People with mental illness can safely and effectively take Ozempic or other glucagon-like peptide-1 receptor agonist (GLP1-RA) drugs without it negatively impacting their mental health or the use of antidepressants, according to an international review presented at the European Congress on Obesity.
Aripiprazole, ziprasidone, lurasidone, cariprazine and lumateperone are less likely to cause weight gain than the others, but that can vary from person to person. Antidepressants. These are sometimes used with a mood stabilizer or antipsychotic.
Finding Your Ideal Diet
Excessive amounts of sugar, caffeine, alcohol or chocolate may be more likely to contribute to mood disturbance. Foods such as such as vegetables, fruit, oil-rich fish and whole grains may be more likely help with stability.
One of the most common side effects—especially with mood stabilizers and antipsychotic medications—is weight gain. Medications like valproic acid and some second-generation antipsychotics can increase appetite, slow metabolism, and disrupt sleep patterns, making it harder to maintain a healthy routine.
Does lamotrigine cause weight loss? Lamotrigine does not usually affect weight at all.
Get some exercise
Depending on the type of exercise you do, physical activity can help boost your metabolism to lose weight or at least prevent further weight gain. Exercise also helps lift your mood and lower anxiety without the additional side effects of mood-lifting medications like antidepressants.
According to the DSM-5, racing thoughts can only be found in depressive and bipolar disorders. Thus, racing thoughts are not expected to be found in adults with ADHD.
Open studies suggest that topiramate may have mood-stabilizing properties for the treatment of bipolar disorder 2, 6. Topiramate also offers the advantage of weight loss, which may be especially useful in obese bipolar subjects who also have type II diabetes mellitus.
Topiramate (Topamax). More research is needed to know if this anticonvulsant can treat bipolar disorder. It can lead to weight loss, but it can also cause dizziness, fatigue, and nervousness.
"Ozempic hands" is a slang term for the skeletal or aged appearance hands can develop due to rapid fat loss from medications like Ozempic (semaglutide), where thinner skin reveals more prominent veins, tendons, and bones, resulting in a loss of fullness. It's not a formal diagnosis but describes a visible sign of significant weight loss, similar to "Ozempic face" or "Ozempic feet," caused by reduced subcutaneous fat and skin not contracting quickly enough.
It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
How many hours should a bipolar person sleep? People should try to sleep at least 7 hours per night, regardless of whether they have a condition such as bipolar disorder.
On a background of minor dysmorphologies of the upper face, maxilla, midface and periorbital region, the main features in bipolar disorder are (a) retrusion and shortening of the premaxilla, nose, philtrum, lips and mouth (the frontonasal prominences), with (b) protrusion and widening of the mandible-chin.
Case reports indicated that the use of phentermine in patients with bipolar disorder may lead to manic or hypomanic episodes,28-31) and the report of Allison et al. 33) suggested that phentermine may induce or aggravate depression in some patients.
How long will it take to shed 30 lbs on Ozempic? On average, losing 30 pounds occurs within 5-6 months of sustained treatment.
CAPLYTA® (lumateperone) is a prescription medicine used in adults along with an antidepressant to treat major depressive disorder (MDD); to treat depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression) alone or with lithium or valproate; or to treat schizophrenia.
Those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN2), pancreatitis, or gallbladder disease are not suitable candidates for Ozempic. In addition, this treatment is not intended for pregnant or breastfeeding women.